Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04411173 · ClinicalTrials.gov registry record · NA
Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations
A NA study of Hypertrophy, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT04411173: Completed NA study of Hypertrophy, sponsored by Lindenwood University.
NCT04411173 is a NA study of Hypertrophy that has completed, run by Lindenwood University. The registered enrollment target is 24 participants, below the 32-participant average among 4 other Hypertrophy trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04411173, a NA study of Hypertrophy, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the ability of isocaloric and isonitrogenous (2 x 15-gram) doses of rice protein or whey protein to stimulate resistance training adaptations in young, healthy, resistance-trained men.
Primary Outcome
Examining how much strength each participant gains (or loses) from Day 1 to Final day
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Whey Protein
Study Locations (1)
Missouri
- Lindenwood University - Saint Charles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-09-12 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
What the finished NCT04411173 record still lists
NCT04411173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 32-participant average among 4 other Hypertrophy trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Hypertrophy appearing as the primary indexed condition, and to 1 intervention - of which Whey Protein is the first listed.
NCT04411173 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04411173 about?
NCT04411173 is a clinical study titled "Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations". The purpose of this study is to compare the ability of isocaloric and isonitrogenous (2 x 15-gram) doses of rice protein or whey protein to stimulate resistance training adaptations in young, healthy, resistance-trained men.
What is the current status of trial NCT04411173?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-09-12. Estimated completion is 2020-02-12.
What conditions does trial NCT04411173 study?
This clinical trial studies the following conditions: Hypertrophy.
What interventions are being tested in trial NCT04411173?
The interventions under investigation include: Whey Protein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04411173?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04411173 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI